文献速递生殖医学

基于子宫内膜液微小RNA的特征可识别具有种植能力的子宫内膜

microRNA-based signatures obtained from endometrial fluid identify implantative endometrium.
PubMed 文献 · Hum Reprod · 2022-01-01

该前瞻性研究优化了子宫内膜液(EF)中游离及细胞外囊泡相关微小RNA(miRNA)的分析方案,并在发现队列(成功种植15例/失败15例)和验证队列(成功30例/失败30例)中构建并验证了基于三种miRNA的预测模型,用于无创区分具有种植能力与无种植能力的子宫内膜。

要点

  • 基于细胞外囊泡富集的方案比直接RNA提取检测到更多miRNA。
  • Model 1(PBP-M)发现队列AUC=0.93(P=0.003),验证队列AUC=0.69(P=0.019)。
  • Model 2(PBP-N)发现队列AUC=0.92(P=0.0002),验证队列AUC=0.78(P=0.0002)。

核心结论

  • 游离及细胞外囊泡相关miRNA可以无创方式检测具有种植能力的子宫内膜。

研究设计与样本

  • 前瞻性研究,首先在设置队列(n=72)中优化细胞外囊泡和miRNA分析方案。
  • 发现队列成功种植15例、失败15例;验证队列成功种植30例、失败30例。
  • 成功种植定义为胚胎移植后4周阴道超声显示妊娠囊确认妊娠。

主要发现

  • 使用聚合物沉淀法(PBP)的两种方案PBP-M和PBP-N最为有效,各构建了基于三种miRNA的预测模型。
  • Model 1(PBP-M)使用hsa-miR-200b-3p、hsa-miR-24-3p和hsa-miR-148b-3p:发现队列AUC=0.93(P=0.003),验证队列AUC=0.69(P=0.019)。
  • Model 2(PBP-N)使用hsa-miR-200b-3p、hsa-miR-24-3p和hsa-miR-99b-5p:发现队列AUC=0.92(P=0.0002),验证队列AUC=0.78(P=0.0002)。
  • 功能分析显示这些miRNA与子宫内胚胎发育或转化生长因子-β信号传导等关键种植过程强相关。

临床怎么用

  • 作者描述的新无创方案可用于分析少量子宫内膜液中的miRNA,并认为可在临床实践中用于胚胎移植前评估子宫内膜状态。
  • 作者认为这种评估可能有助于避免将胚胎移植到无种植能力的子宫内膜而造成胚胎丢失。

局限性

  • 试验中女性之间及移植胚胎之间存在固有变异性。
  • 胚胎仅基于形态学预选,未进行遗传学或分子学研究,而后者本可提高检测准确性。
  • miRNA文库构建的局限在于输入RNA量低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is it possible to use free and extracellular vesicle-associated microRNAs (miRNAs) from human endometrial fluid (EF) samples as non-invasive biomarkers for implantative endometrium? SUMMARY ANSWER: The free and extracellular vesicle-associated miRNAs can be used to detect implantative endometrium in a non-invasive manner. WHAT IS KNOWN ALREADY: miRNAs and extracellular vesicles (EVs) from EF have been described as mediators of the embryo-endometrium crosstalk. Therefore, the analysis of miRNA from this fluid could become a non-invasive technique for recognizing implantative endometrium. This analysis could potentially help improve the implantation rates in ART. STUDY DESIGN, SIZE, DURATION: In this prospective study, we first optimized different protocols for EVs and miRNA analyses using the EF of a setup cohort (n = 72). Then, we examined differentially expressed miRNAs in the EF of women with successful embryo implantation (discovery cohort n = 15/validation cohort n = 30) in comparison with those for whom the implantation had failed (discovery cohort n = 15/validation cohort n = 30). Successful embryo implantation was considered when pregnancy was confirmed by vaginal ultrasound showing a gestational sac 4 weeks after embryo transfer (ET). PARTICIPANTS/MATERIALS, SETTING, METHODS: The EF of the setup cohort was obtained before starting fertility treatment during the natural cycle, 16-21 days after the beginning of menstruation. For the discovery and validation cohorts, the EF was collected from women undergoing frozen ET on Day 5, and the samples were collected immediately before ET. In this study, we compared five different methods; two of them based on direct extraction of RNA and the other three with an EV enrichment step before the RNA extraction. Small RNA sequencing was performed to determine the most efficient method and find a predictive model differentiating between implantative and non-implantative endometrium. The models were confirmed using quantitative PCR in two sets of samples (discovery and validation cohorts) with different implantation outcomes. MAIN RESULTS AND THE ROLE OF CHANCE: The protocols using EV enrichment detected more miRNAs than the methods based on direct RNA extraction. The two most efficient protocols (using polymer-based precipitation (PBP): PBP-M and PBP-N) were used to obtain two predictive models (based on three miRNAs) allowing us to distinguish between an implantative and non-implantative endometrium. The first Model 1 (PBP-M) (discovery: AUC = 0.93; P-value = 0.003; validation: AUC = 0.69; P-value = 0.019) used hsa-miR-200b-3p, hsa-miR-24-3p and hsa-miR-148b-3p. Model 2 (PBP-N) (discovery: AUC = 0.92; P-value = 0.0002; validation: AUC = 0.78; P-value = 0.0002) used hsa-miR-200b-3p, hsa-miR-24-3p and hsa-miR-99b-5p. Functional analysis of these miRNAs showed strong association with key implantation processes such as in utero embryonic development or transforming growth factor-beta signaling. LARGE SCALE DATA: The FASTQ data are available in the GEO database (access number GSE178917). LIMITATIONS, REASONS FOR CAUTION: One important factor to consider is the inherent variability among the women involved in the trial and among the transferred embryos. The embryos were pre-selected based on morphology, but neither genetic nor molecular studies were conducted, which would have improved the accuracy of our tests. In addition, a limitation in miRNA library construction is the low amount of input RNA. WIDER IMPLICATIONS OF THE FINDINGS: We describe new non-invasive protocols to analyze miRNAs from small volumes of EF. These protocols could be implemented in clinical practice to assess the status of the endometrium before attempting ET. Such evaluation could help to avoid the loss of embryos transferred to a non-implantative endometrium. STUDY FUNDING/COMPETING INTEREST(S): J.I.-P. was supported by a predoctoral grant from the Basque Government (PRE_2017_0204). This study was partially funded by the Grant for Fertility Innovation (GFI, 2011) from Merck (Darmstadt, Germany). It was also supported by the Spanish Ministry of Economy and Competitiveness MINECO within the National Plan RTI2018-094969-B-I00, the European Union's Horizon 2020 research and innovation program (860303), the Severo Ochoa Centre of Excellence Innovative Research Grant (SEV-2016-0644) and the Instituto de Salud Carlos III (PI20/01131). The funding entities did not play any role in the study design, collection, analysis and interpretation of data, writing of the report or the decision to submit the article for publication. The authors declare no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ibañez-Perez J, Díaz-Nuñez M, Clos-García M, et al. microRNA-based signatures obtained from endometrial fluid identify implantative endometrium. Hum Reprod. 2022. PMID: 36029522. doi:10.1093/humrep/deac184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。